Propionyl-L-carnitine improves hemodynamics and metabolic markers of cardiac perfusion during coronary surgery in diabetic patients

被引:25
作者
Lango, R
Smolenski, RT
Rogowski, J
Siebert, J
Wujtewicz, M
Slominska, EM
Lysiak-Szydlowska, W
Yacoub, MH
机构
[1] Med Univ Gdansk, Dept Anesthesiol & Intens Care, PL-80211 Gdansk, Poland
[2] Imperial Coll, Harefield Hosp, Heart Sci Ctr, Harefield, Middx, England
[3] Med Univ Gdansk, Dept Biochem, PL-80211 Gdansk, Poland
[4] Med Univ Gdansk, Dept Cardiac Surg, PL-80211 Gdansk, Poland
[5] Med Univ Gdansk, Dept Family Med, PL-80211 Gdansk, Poland
[6] Med Univ Gdansk, Dept Clin Nutr, PL-80211 Gdansk, Poland
关键词
L-carnitine; propionyl-L-carnitine; coronary surgery; diabetes mellitus; endothelin; hemodynamics; hypoxanthine; reperfusion;
D O I
10.1007/s10557-005-3349-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic hearts are particularly vulnerable to ischemia-reperfusion injury during cardiac surgery. Application of carnitine derivatives could be beneficial not only because of metabolic effects hut also by protecting vasculature. This study aimed to evaluate hemodynamic changes associated with propionyl-L-carnitine and L-carnitine administration and its correlation with biochemical markers of cardiac vascular function. Methods: Sixty-eight diabetic patients undergoing cardiopulmonary bypass coronary operation were given intravenously 20 mg/kg b.w. L-carnitine (LC), 24 mg/kg b.w. propionyl-L-carnitine (PC), or placebo (Cont). Endothelin and nucleotide metabolites were determined intraoperatively in arterial and coronary sinus blood and heart biopsies. Results: Cardiac index at 6 and 12 It after cardiopulmonary bypass was significantly higher in PC (3.30 +/- 0.12 and 3.47 +/- 0.15 L/min/m(2)) as compared to Cont (2.92 +/- 0.13 and 2.91 +/- 0.16 L/min/m(2); P = 0.04 and P = 0.01, respectively). Mean pulmonary artery pressure was lower in PC at 6 (20.8 +/- 0.91 mmHg) and 12 h (20.7 +/- 0.81 mmHg) in comparison to Cont (23.5 +/- 0.75 and 23.4 +/- 0.75 mmHg; P = 0.03 and P = 0.02, respectively). Trans-cardiac endothelin difference on reperfusion was higher in Cont (0.33 +/- 0.26 pmol/L) than in LC (-0.61 +/- 0.24 pmol/L, P = 0.012) and tended to be higher than in PC (-0.29 +/- 0.17 pmol/L, P = 0.056). Trans-cardiac hypoxanthine difference after 10 min reperfusion was significantly higher in Cont (6.22 +/- 1.08 mu mol/L) in comparison to LC (3.17 +/- 0.66 mu mol/L, P = 0.025) and PC (2.36 +/- 0.73 mu mol/L, P = 0.006). Myocardial hypoxanthine concentration was lowest in PC. Conclusions: Significant improvement of hemodynamics following propionyl-L-carnitine administration in diabetic patients undergoing on-bypass coronary surgery was accompanied by reduced trans-cardiac endothelin difference and rapid hypoxanthine washout during reperfusion suggesting improvement of metabolism or vascular function.
引用
收藏
页码:267 / 275
页数:9
相关论文
共 27 条
[1]   Acute and chronic effects of propinoyl-L-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure [J].
Anand, I ;
Chandrashekhan, Y ;
De Giuli, F ;
Pasini, E ;
Mazzoletti, A ;
Confortini, R ;
Ferrari, R .
CARDIOVASCULAR DRUGS AND THERAPY, 1998, 12 (03) :291-299
[2]   ACUTE IMPROVEMENT OF CARDIAC-FUNCTION WITH INTRAVENOUS L-PROPIONYLCARNITINE IN HUMANS [J].
BARTELS, GL ;
REMME, WJ ;
PILLAY, M ;
SCHONFELD, DHW ;
COX, PH ;
KRUIJSSEN, HACM ;
KNUFMAN, NMJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 (01) :157-164
[3]  
BERTELLI A, 1992, DRUG EXP CLIN RES, V18, P349
[4]  
CEDERBLAD G, 1986, CLIN CHEM, V32, P342
[5]   HEMODYNAMIC-STUDY OF INTRAVENOUS PROPIONYL-L-CARNITINE IN PATIENTS WITH ISCHEMIC-HEART-DISEASE AND NORMAL LEFT-VENTRICULAR FUNCTION [J].
CHIDDO, A ;
GAGLIONE, A ;
MUSCI, S ;
TROITO, G ;
GRIMALDI, N ;
LOCURATOLO, N ;
RIZZON, P .
CARDIOVASCULAR DRUGS AND THERAPY, 1991, 5 :107-112
[6]   Propionyl-L-carnitine dilates human subcutaneous arteries through an endothelium-dependent mechanism [J].
Cipolla, MJ ;
Nicoloff, A ;
Rebello, T ;
Amato, A ;
Porter, JM .
JOURNAL OF VASCULAR SURGERY, 1999, 29 (06) :1097-1103
[7]   Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus [J].
Cohen, Y ;
Raz, I ;
Merin, G ;
Mozes, B .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (01) :7-11
[8]   Pathogenetic concepts of acute coronary syndromes [J].
Corti, R ;
Fuster, V ;
Badimon, JJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (04) :7S-14S
[9]  
Evangeliou A., 2003, Current Pharmaceutical Biotechnology, V4, P211, DOI 10.2174/1389201033489829
[10]  
GOLBA K, 2000, KARDIOL POL, V52, P181